Recent Content
- Navigating Multiple Myeloma Care: Balancing CAR T-Cell Therapy and Immunotherapy
- Boruzu Approved by FDA For Multiple Myeloma, Mantle Cell Lymphoma
- Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma
- Moving Forward in Multiple Myeloma: Earlier Lines of CAR-T Cell Therapy
- Speeding Up With CAR-T Cell Therapy in Multiple Myeloma
- IL-10R inhibition reprograms tumor-associated macrophages and reverses drug resistance in multiple myeloma
- Multiple Myeloma Remission: A Glimmer of Hope
- 10 Multiple Myeloma Questions and Answers: Treatments and Side Effects
- The Solitude of Reality With Multiple Myeloma
- The TGFβ type I receptor kinase inhibitor vactosertib in combination with pomalidomide in relapsed/refractory multiple myeloma: a phase 1b trial